Literature DB >> 20663578

Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy.

Taran Paulsen Hellebust1, Christian Kirisits, Daniel Berger, José Pérez-Calatayud, Marisol De Brabandere, Astrid De Leeuw, Isabelle Dumas, Robert Hudej, Gerry Lowe, Rachel Wills, Kari Tanderup.   

Abstract

Image-guided brachytherapy in cervical cancer is increasingly replacing X-ray based dose planning. In image-guided brachytherapy the geometry of the applicator is extracted from the patient 3D images and introduced into the treatment planning system; a process referred to as applicator reconstruction. Due to the steep brachytherapy dose gradients, reconstruction errors can lead to major dose deviations in target and organs at risk. Appropriate applicator commissioning and reconstruction methods must be implemented in order to minimise uncertainties and to avoid accidental errors. Applicator commissioning verifies the location of source positions in relation to the applicator by using auto-radiography and imaging. Sectional imaging can be utilised in the process, with CT imaging being the optimal modality. The results from the commissioning process can be stored as library applicators. The importance of proper commissioning is underlined by the fact that errors in library files result in systematic errors for clinical treatment plans. While the source channel is well visualised in CT images, applicator reconstruction is more challenging when using MR images. Availability of commercial dummy sources for MRI is limited, and image artifacts may occur with titanium applicators. The choice of MR sequence is essential for optimal visualisation of the applicator. Para-transverse imaging (oriented according to the applicator) with small slice thickness (< or =5 mm) is recommended or alternatively 3D MR sequences with isotropic voxel sizes. Preferably, contouring and reconstruction should be performed in the same image series in order to avoid fusion uncertainties. Clear and correct strategies for the applicator reconstruction will ensure that reconstruction uncertainties have limited impact on the delivered dose. Under well-controlled circumstances the reconstruction uncertainties are in general smaller than other brachytherapy uncertainties such as contouring and organ movement. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20663578     DOI: 10.1016/j.radonc.2010.06.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  94 in total

Review 1.  The role of imaging in the management of non-metastatic cervical cancer.

Authors:  Orit Kaidar-Person; Roxolyana Bortnyak-Abdah; Amnon Amit; Alison Berniger; Rahamim Ben-Yosef; Abraham Kuten
Journal:  Med Oncol       Date:  2012-04-25       Impact factor: 3.064

2.  The changing landscape of brachytherapy for cervical cancer: a Canadian practice survey.

Authors:  T Phan; L Mula-Hussain; S Pavamani; A Pearce; D D'Souza; N G Patil; L Traptow; C M Doll
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

Review 3.  Review of strategies for MRI based reconstruction of endocavitary and interstitial applicators in brachytherapy of cervical cancer.

Authors:  José Richart; Vicente Carmona-Meseguer; Teresa García-Martínez; Antonio Herreros; Antonio Otal; Santiago Pellejero; Ana Tornero-López; José Pérez-Calatayud
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-23

4.  Magnetic resonance image-guided brachytherapy for cervical cancer : Prognostic factors for survival.

Authors:  Yeon-Joo Kim; Joo-Young Kim; Youngkyong Kim; Young Kyung Lim; Jonghwi Jeong; Chiyoung Jeong; Meyoung Kim; Myong Cheol Lim; Sang-Soo Seo; Sang-Yoon Park
Journal:  Strahlenther Onkol       Date:  2016-10-12       Impact factor: 3.621

Review 5.  A review of recent developments in image-guided radiation therapy in cervix cancer.

Authors:  Azmat H Sadozye; Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

Review 6.  In vivo dosimetry: trends and prospects for brachytherapy.

Authors:  G Kertzscher; A Rosenfeld; S Beddar; K Tanderup; J E Cygler
Journal:  Br J Radiol       Date:  2014-07-08       Impact factor: 3.039

7.  Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.

Authors:  Justin K Mikell; Ann H Klopp; Graciela M N Gonzalez; Kelly D Kisling; Michael J Price; Paula A Berner; Patricia J Eifel; Firas Mourtada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-19       Impact factor: 7.038

8.  MRI-based treatment planning and dose delivery verification for intraocular melanoma brachytherapy.

Authors:  Jacqueline Esthappan Zoberi; Jose Garcia-Ramirez; Samantha Hedrick; Vivian Rodriguez; Carol G Bertelsman; Stacie Mackey; Yanle Hu; H Michael Gach; P Kumar Rao; Perry W Grigsby
Journal:  Brachytherapy       Date:  2017-08-14       Impact factor: 2.362

Review 9.  MRI-only treatment planning: benefits and challenges.

Authors:  Amir M Owrangi; Peter B Greer; Carri K Glide-Hurst
Journal:  Phys Med Biol       Date:  2018-02-26       Impact factor: 3.609

Review 10.  Magnetic resonance image guided brachytherapy.

Authors:  Kari Tanderup; Akila N Viswanathan; Christian Kirisits; Steven J Frank
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.